Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Dutch Cancer Society

InstitutionResearch output, impact & collaborations

Dutch Cancer Society is a research organisation in Amsterdam, NL. OpenAlex records 2,654 works and 165,029 citations for it. 1,055 researchers list it as their most recent affiliation.

2,654
Works
165,029
Citations
1,055
Researchers
62.5
Avg h-index

How has Dutch Cancer Society's publication output changed over time?

ScholarIQpublication output · 2007–2022

Output grew0% over the shown period — from 1 works in 2007 to 1 in 2022.

1
1
2
1
1
1
1
3
1
200720082010201420152016201920202022

Who are the most-cited researchers behind Dutch Cancer Society?

ScholarIQtop researchers by citations
1
Marc G. Besselink · Pancreatic and Hepatic Oncology Research
1,890 works62,842 citations
2
Freek Daams · Pancreatic and Hepatic Oncology Research
330 works7,733 citations
3
A. Masie Rahimi · Surgical Simulation and Training
12 works133 citations
4
Catherina E. Korse · Neuroendocrine Tumor Research Advances
1 works7 citations
5
Freek Daams · Surgical Simulation and Training
11 works0 citations

What are the most-cited papers on Dutch Cancer Society?

ScholarIQmost cited works
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi, Giovanni Marchegiani, Christos Dervenis, M. G. Sarr, Mohammad Abu Hilal, Mustapha Adham, Peter Allen, Roland Andersson, Horacio J. Asbun, Marc G. Besselink, Kevin C. Conlon, Marco Del Chiaro, Massimo Falconi, Laureano Fernández‐Cruz, Carlos Fernández‐del Castillo, Abe Fingerhut, Helmut Frieß, Dirk J. Gouma, Thilo Hackert, Jakob R. Izbicki, Keith D. Lillemoe, John P. Neoptolemos, Attila Oláh, Richard D. Schulick, Shailesh V. Shrikhande, Tadahiro Takada, Kyoichi Takaori, William Traverso, C. Vollmer, Christopher L. Wolfgang, Charles J. Yeo, Roberto Salvia, Marcus Büchler
Surgery. 20164,239 Citations
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
The Lancet Oncology. 20152,588 Citations
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Louis Vermeulen, Felipe de Sousa e Melo, Maartje van der Heijden, Kate Cameron, Joan H. de Jong, Tijana Borovski, Jurriaan B. Tuynman, Matilde Todaro, Christian J. Merz, Hans M. Rodermond, Martin R. Sprick, Kristel Kemper, Dick J. Richel, Giorgio Stassi, Jan Paul Medema
S151741590. 20101,794 Citations
A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis
Hjalmar C. van Santvoort, Marc G. Besselink, Olaf J. Bakker, H. Sijbrand Hofker, Marja A. Boermeester, Cornelis H.C. Dejong, Harry van Goor, Alexander F. Schaapherder, Casper H.J. van Eijck, Thomas L. Bollen, Bert van Ramshorst, Vincent B. Nieuwenhuijs, Robin Timmer, Johan S. Laméris, Philip M. Kruyt, Eric R. Manusama, Erwin van der Harst, George P. van der Schelling, Tom M. Karsten, E. J. Hesselink, Cornelis JHM van Laarhoven, Camiel Rosman, Koop Bosscha, Ralph J. de Wit, Alexander P. J. Houdijk, Maarten S. van Leeuwen, Erik Buskens, Hein G. Gooszen
New England Journal of Medicine. 20101,709 CitationsOPEN ACCESS
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, Corrie A.M. Marijnen, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Annet G.H. Roodvoets, Irıs D. Nagtegaal, Regina G. H. Beets‐Tan, Lennart K. Blomqvist, Tone Fokstuen, Albert J. ten Tije, Jaume Capdevila, Mathijs P. Hendriks, Ibrahim Edhemović, Andrés Cervantes, Per J. Nilsson, Bengt Glimelius, Cornelis J.�H. van de Velde, Geke A.P. Hospers, Lars Østergaard, Frank Svendsen Jensen, Per Pfeiffer, K.E.J. Jensen, Mathijs P. Hendriks, Wilhelmina H. Schreurs, H.P. Knol, J.J. van der Vliet, Jurriaan B. Tuynman, A. Bruynzeel, Emile D. Kerver, Sebastiaan Festen, Monique E. van Leerdam, Geerard L. Beets, L. Dewit, C.J.A. Punt, Pieter J. Tanis, Elisabeth D. Geijsen, Peter Nieboer, Wim Bleeker, Albert J. ten Tije, Rogier M. P. H. Crolla, Addy C.M. van de Luijtgaarden, Jan Willem T. Dekker, J.M. Immink, Frank J. Jeurissen, Andreas Marinelli, Heleen M. Ceha, Tanja C. Stam, P. Quarles an Ufford, Willem H. Steup, Alex L.T. Imholz, R.J.I. Bosker, Jasper Bekker, G.J. Creemers, Grard A. P. Nieuwenhuijzen, Henk van den Berg, Wendy M. van der Deure, Roderick F. Schmitz, Johan M. van Rooijen, Annette F. T. Olieman, A.C.M. van den Bergh, Derk Jan A. de Groot, Klaas Havenga, Jannet C. Beukema, Jacob D. de Boer, Peter H.J.M. Veldman, Ester Siemerink, J.W.P. Vanstiphout, B. De Valk, Q. A. J. Eijsbouts, M. Polée, Christiaan Hoff, Annerie Slot, H.W. Kapiteijn, Koen Peeters, Femke P. Peters, P.A. Nijenhuis, Sandra A. Radema, Hans De Wilt, Pètra M. Braam, G.J. Veldhuis, Daniël A. Hess, Tom Rozema, O. Reerink, Daan ten Bokkel Huinink, A. Pronk, Josephine M. I. Vos, Metin Tascilar, Gijs A. Patijn, Christian Kersten, Odd Mjåland, Marianne G. Guren, Arild Nesbakken, Janez Benedik, Ibrahim Edhemović, Vaneja Velenik, Jaume Capdevila, Eloy Espín, Ramón Salazar
The Lancet Oncology. 20201,669 CitationsOPEN ACCESS

How much of the research on Dutch Cancer Society is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
42%
Hybrid
0%
Bronze
25%
Closed
33%

Related on ScholarIQ

Cancer Immunotherapy and Biomarkers
Top Topic
Breast Cancer Treatment Studies
Top Topic
Cancer Genomics and Diagnostics
Top Topic
Radiomics and Machine Learning in Medical Imaging
Top Topic
Pancreatic and Hepatic Oncology Research
Top Topic
Cancer survivorship and care
Top Topic
470M+ articles · free account